Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children

被引:0
|
作者
M Kondo
S Kojima
K Horibe
K Kato
T Matsuyama
机构
[1] Okazaki City Hospital,Department of Pediatrics
[2] Nagoya University School of Medicine,Department of Pediatrics
[3] Children's Medical Center,Division of Hematology/Oncology
[4] Japanese Red Cross Nagoya First Hospital,undefined
来源
关键词
chronic GVHD; stem cell transplantation; risk factor; children;
D O I
暂无
中图分类号
学科分类号
摘要
We analyzed the incidence and risk factors for chronic graft-versus-host disease (GVHD) in 265 children undergoing allogeneic stem cell transplantation (SCT) who survived longer than 3 months post SCT. Patients transplanted from HLA-mismatched related donors and matched unrelated donors were included. Fifty-five patients developed chronic GVHD between 1 and 25 months after SCT, and the 5-year cumulative incidence of chronic GVHD was 22%. By multivariate analysis, acute GVHD (P = 0.004), malignant disease (P = 0.004), recipient age (⩾10 years) (P = 0.01) and a female donor to male recipient (P = 0.035) were significant risk factors for chronic GVHD. When acute GVHD was excluded from the multivariate analysis, malignant disease (P = 0.002) and older recipient age (P = 0.007) were identified. The incidence of chronic GVHD in this childhood study was lower than that observed in adults, and recipient age was an important factor in childhood SCT. The high incidence associated with malignant disease may be affected by changes in GVHD prophylaxis in order to ensure graft-versus-tumor effects. Bone Marrow Transplantation (2001) 27, 727–730.
引用
收藏
页码:727 / 730
页数:3
相关论文
共 50 条
  • [1] Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children
    Kondo, M
    Kojima, S
    Horibe, K
    Kato, K
    Matsuyama, T
    BONE MARROW TRANSPLANTATION, 2001, 27 (07) : 727 - 730
  • [2] Incidence of and risk factors for chronic graft-versus-host disease in children given an allogeneic haematopoietic stem cell transplantation
    Zecca, M
    Pession, A
    Rondelli, R
    Lanino, E
    Uderzo, C
    Messina, C
    Fagioli, F
    Porta, F
    Locatelli, F
    Prete, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S5 - S5
  • [3] Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic stem cell transplantation
    Remberger, M
    Kumlien, G
    Aschan, J
    Barkholt, L
    Hentschke, P
    Ljungman, P
    Mattsson, J
    Svennilson, J
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2002, 29 : S170 - S170
  • [4] Chronic graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Anderlini, P
    Saliba, R
    Cleary, K
    Mehra, R
    Khouri, I
    Huh, YO
    Giralt, S
    Braunschweig, I
    van Besien, K
    Champlin, R
    BLOOD, 2001, 98 (06) : 1695 - 1700
  • [5] Chronic graft-versus-host disease is a risk factor for hyposplenism after allogeneic stem cell transplantation
    Martinez, M. T.
    Rovo, A.
    Baldomero, H.
    Halter, J.
    Gerull, S.
    Lehmann, T.
    Passweg, J. R.
    Tichelli, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S347 - S348
  • [6] Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation
    Przepiorka, D
    Smith, TL
    Folloder, J
    Khouri, I
    Ueno, NT
    Mehra, R
    Körbling, M
    Huh, YO
    Giralt, S
    Gajewski, J
    Donato, M
    Cleary, K
    Claxton, D
    Braunschweig, I
    van Besien, K
    Andersson, BS
    Anderlini, P
    Champlin, R
    BLOOD, 1999, 94 (04) : 1465 - 1470
  • [7] Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Remberger, M
    Kumlien, G
    Aschan, J
    Barkholt, L
    Hentschke, P
    Ljungman, P
    Mattsson, J
    Svennilson, J
    Ringdén, O
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (12) : 674 - 682
  • [8] Sclerodermatous chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation:: incidence, outcome and risk factors
    Skert, C
    Patriarca, F
    Damiani, D
    Cerno, M
    Filì, C
    Geromin, A
    Sperotto, A
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S151 - S151
  • [9] Risk factors for acute and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in paediatric patients
    Kim, M. S.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S112 - S113
  • [10] Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation
    Pavletic, SZ
    Smith, LM
    Bishop, MR
    Lynch, JC
    Tarantolo, SR
    Vose, JM
    Bierman, PJ
    Hadi, A
    Armitage, JO
    Kessinger, A
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (04) : 265 - 274